anti kdr antibody Search Results


93
Miltenyi Biotec kdr
A) Schematic representation of the cardiac organoid differentiation protocol. B) Semiquantitative RT-PCR detecting mesodermal ( TBXT, <t>KDR,</t> GATA4 ), cardiac ( NKX2 . 5, TBX5, ISL1, TNNT2, DES, RYR2 ), and endothelial <t>(</t> <t>PECAM1</t> ) marker gene expression. C) H&E staining of organoid section at day 2. D-D’) Immunofluorescence analyses detecting early mesodermal markers TBXT and VIM. E) Immunofluorescence analyses detecting early mesodermal markers GATA6 and KDR. F) H&E staining showing hollow cavity-like structures in cardiac organoids at day 8. G-G’) Immunofluorescence analyses detecting mesenchymal cells (VIM + ) in close association with cardiomyocytes (TNNT2 + ). H) H&E staining of organoid sections at day 35 of culture. I) Immunofluorescence analyses showing close interaction of fibroblasts (VIM + ) and cardiomyocytes (TNNT2 + ) at day 35 of culture. J) Cardiac organoids progressively gain in size (D0 = 12.2 μm ± 6.85; D7 = 1231 ± 20.31; D25 = 1613 ± 45.43). K) Beating frequency increases over culture time starting from 25 bpm (± 1.9) at day 7 up to 57 bpm (± 10.5) at day 35. Scale in all pictures: 50 µm
Kdr, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/CD309+(VEGFR-2)+Antibody%2C+anti-mouse/bio_rxiv__2025__05__20__654824-146-13-14
Average 93 stars, based on 1 article reviews
kdr - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Miltenyi Biotec anti human cd309
A) Schematic representation of the cardiac organoid differentiation protocol. B) Semiquantitative RT-PCR detecting mesodermal ( TBXT, <t>KDR,</t> GATA4 ), cardiac ( NKX2 . 5, TBX5, ISL1, TNNT2, DES, RYR2 ), and endothelial <t>(</t> <t>PECAM1</t> ) marker gene expression. C) H&E staining of organoid section at day 2. D-D’) Immunofluorescence analyses detecting early mesodermal markers TBXT and VIM. E) Immunofluorescence analyses detecting early mesodermal markers GATA6 and KDR. F) H&E staining showing hollow cavity-like structures in cardiac organoids at day 8. G-G’) Immunofluorescence analyses detecting mesenchymal cells (VIM + ) in close association with cardiomyocytes (TNNT2 + ). H) H&E staining of organoid sections at day 35 of culture. I) Immunofluorescence analyses showing close interaction of fibroblasts (VIM + ) and cardiomyocytes (TNNT2 + ) at day 35 of culture. J) Cardiac organoids progressively gain in size (D0 = 12.2 μm ± 6.85; D7 = 1231 ± 20.31; D25 = 1613 ± 45.43). K) Beating frequency increases over culture time starting from 25 bpm (± 1.9) at day 7 up to 57 bpm (± 10.5) at day 35. Scale in all pictures: 50 µm
Anti Human Cd309, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/CD309+(VEGFR-2)+Antibody%2C+anti-human/pmc08348107-176-71-77
Average 94 stars, based on 1 article reviews
anti human cd309 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Miltenyi Biotec cd309 vegfr 2 antibody
A) Schematic representation of the cardiac organoid differentiation protocol. B) Semiquantitative RT-PCR detecting mesodermal ( TBXT, <t>KDR,</t> GATA4 ), cardiac ( NKX2 . 5, TBX5, ISL1, TNNT2, DES, RYR2 ), and endothelial <t>(</t> <t>PECAM1</t> ) marker gene expression. C) H&E staining of organoid section at day 2. D-D’) Immunofluorescence analyses detecting early mesodermal markers TBXT and VIM. E) Immunofluorescence analyses detecting early mesodermal markers GATA6 and KDR. F) H&E staining showing hollow cavity-like structures in cardiac organoids at day 8. G-G’) Immunofluorescence analyses detecting mesenchymal cells (VIM + ) in close association with cardiomyocytes (TNNT2 + ). H) H&E staining of organoid sections at day 35 of culture. I) Immunofluorescence analyses showing close interaction of fibroblasts (VIM + ) and cardiomyocytes (TNNT2 + ) at day 35 of culture. J) Cardiac organoids progressively gain in size (D0 = 12.2 μm ± 6.85; D7 = 1231 ± 20.31; D25 = 1613 ± 45.43). K) Beating frequency increases over culture time starting from 25 bpm (± 1.9) at day 7 up to 57 bpm (± 10.5) at day 35. Scale in all pictures: 50 µm
Cd309 Vegfr 2 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/CD309+(VEGFR-2)+Antibody%2C+anti-human%2C+REAfinity/pmc09218765__ADVS___9___2104451___s005-93-41-51
Average 94 stars, based on 1 article reviews
cd309 vegfr 2 antibody - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

91
Miltenyi Biotec human anti mouse monoclonal rea1116
Reagents and resources list for MRPEC isolation.
Human Anti Mouse Monoclonal Rea1116, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/CD309+(VEGFR-2)+Antibody%2C+anti-mouse%2C+REAfinity/pmc09948610-43-9-16
Average 91 stars, based on 1 article reviews
human anti mouse monoclonal rea1116 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

93
Cusabio rabbit polyclonal anti phospho vegfr2 antibody
Reagents and resources list for MRPEC isolation.
Rabbit Polyclonal Anti Phospho Vegfr2 Antibody, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/Rabbit+anti-+Phospho-KDR+Polyclonal+Antibody/pmc09550759-30-7-16
Average 93 stars, based on 1 article reviews
rabbit polyclonal anti phospho vegfr2 antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Boster Bio vegfr2
Immunohistochemical staining for the expression of vascular markers. Positive staining for CD-31 is shown at days (A) 20, (B) 40 and (C) 60; positive staining for Factor-VIII is shown at days (D) 20, (E) 40 and (F) 60; and positive staining of <t>VEGFR2</t> is shown at days (G) 20, (H) 40 and (I) 60. The black arrows indicate the presence of the vascular markers (yellow). CD-31, cluster of differentiation 31; VEGFR2, vascular endothelial growth factor receptor 2.
Vegfr2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/Anti-Flk-1+KDR+Antibody/pmc06423654-78-29-34
Average 94 stars, based on 1 article reviews
vegfr2 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
StressMarq dylight 488 conjugated p vefgr2
Immunohistochemical staining for the expression of vascular markers. Positive staining for CD-31 is shown at days (A) 20, (B) 40 and (C) 60; positive staining for Factor-VIII is shown at days (D) 20, (E) 40 and (F) 60; and positive staining of <t>VEGFR2</t> is shown at days (G) 20, (H) 40 and (I) 60. The black arrows indicate the presence of the vascular markers (yellow). CD-31, cluster of differentiation 31; VEGFR2, vascular endothelial growth factor receptor 2.
Dylight 488 Conjugated P Vefgr2, supplied by StressMarq, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/Anti-VEGFR2+Antibody/pmc07695853-59-15-19
Average 90 stars, based on 1 article reviews
dylight 488 conjugated p vefgr2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ImClone Inc anti-kdr antibody mab 4.13
Immunohistochemical staining for the expression of vascular markers. Positive staining for CD-31 is shown at days (A) 20, (B) 40 and (C) 60; positive staining for Factor-VIII is shown at days (D) 20, (E) 40 and (F) 60; and positive staining of <t>VEGFR2</t> is shown at days (G) 20, (H) 40 and (I) 60. The black arrows indicate the presence of the vascular markers (yellow). CD-31, cluster of differentiation 31; VEGFR2, vascular endothelial growth factor receptor 2.
Anti Kdr Antibody Mab 4.13, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/anti+kdr+antibody+mab+4+13/pm10835110-67-14-21
Average 90 stars, based on 1 article reviews
anti-kdr antibody mab 4.13 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Maixin-Bio ltd anti-human kdr polyclonal antibody
Immunohistochemical staining for the expression of vascular markers. Positive staining for CD-31 is shown at days (A) 20, (B) 40 and (C) 60; positive staining for Factor-VIII is shown at days (D) 20, (E) 40 and (F) 60; and positive staining of <t>VEGFR2</t> is shown at days (G) 20, (H) 40 and (I) 60. The black arrows indicate the presence of the vascular markers (yellow). CD-31, cluster of differentiation 31; VEGFR2, vascular endothelial growth factor receptor 2.
Anti Human Kdr Polyclonal Antibody, supplied by Maixin-Bio ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/polyclonal+antibody+anti+human+kdr/pmc02687458-75-6-10
Average 90 stars, based on 1 article reviews
anti-human kdr polyclonal antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Becton Dickinson pe-mouse anti-kdr monoclonal antibody
Immunohistochemical staining for the expression of vascular markers. Positive staining for CD-31 is shown at days (A) 20, (B) 40 and (C) 60; positive staining for Factor-VIII is shown at days (D) 20, (E) 40 and (F) 60; and positive staining of <t>VEGFR2</t> is shown at days (G) 20, (H) 40 and (I) 60. The black arrows indicate the presence of the vascular markers (yellow). CD-31, cluster of differentiation 31; VEGFR2, vascular endothelial growth factor receptor 2.
Pe Mouse Anti Kdr Monoclonal Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/pe+mouse+anti+kdr+monoclonal+antibody/pmc08370973__41467_2021_24921_MOESM3_ESM-35-0-4
Average 90 stars, based on 1 article reviews
pe-mouse anti-kdr monoclonal antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Becton Dickinson pe-labeled mouse anti-dog kdr antibody
<t>CD133/KDR-positive</t> cells were detected in peripheral blood and identified as circulating EPCs by flow cytometry using counting beads tubes. a Gated and counted beads from a fluorescein isothiocyanate (FITC) versus side-scattering corner (SSC) dot plot. Quadrants were set on the basis of isotype-identical controls. b Dual-positive CD133/KDR cells were identified and numerated in the upper right quadrant of the scatter plot from blood of dogs. The representative dot plots are represented. The absolute counts of positive cells per ml blood were calculated using the equation described in “Methods”. c Comparison of circulating EPCs number before and after PAH. d Differentiated EPCs were significantly reduced in PAH but transiently raised at the early stage after DHMC. Data are mean ± SD. *p < 0.05 versus baseline, # p < 0.05 versus 48 h
Pe Labeled Mouse Anti Dog Kdr Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/pe+labeled+mouse+anti+dog+kdr+antibody/pmc10986842-65-12-16
Average 90 stars, based on 1 article reviews
pe-labeled mouse anti-dog kdr antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Becton Dickinson allophycocyaninconjugated anti-human kdr monoclonal antibody
<t>CD133/KDR-positive</t> cells were detected in peripheral blood and identified as circulating EPCs by flow cytometry using counting beads tubes. a Gated and counted beads from a fluorescein isothiocyanate (FITC) versus side-scattering corner (SSC) dot plot. Quadrants were set on the basis of isotype-identical controls. b Dual-positive CD133/KDR cells were identified and numerated in the upper right quadrant of the scatter plot from blood of dogs. The representative dot plots are represented. The absolute counts of positive cells per ml blood were calculated using the equation described in “Methods”. c Comparison of circulating EPCs number before and after PAH. d Differentiated EPCs were significantly reduced in PAH but transiently raised at the early stage after DHMC. Data are mean ± SD. *p < 0.05 versus baseline, # p < 0.05 versus 48 h
Allophycocyaninconjugated Anti Human Kdr Monoclonal Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+kdr+antibody/allophycocyaninconjugated+anti+human+kdr+monoclonal+antibody/pm21605479-72-17-21
Average 90 stars, based on 1 article reviews
allophycocyaninconjugated anti-human kdr monoclonal antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


A) Schematic representation of the cardiac organoid differentiation protocol. B) Semiquantitative RT-PCR detecting mesodermal ( TBXT, KDR, GATA4 ), cardiac ( NKX2 . 5, TBX5, ISL1, TNNT2, DES, RYR2 ), and endothelial ( PECAM1 ) marker gene expression. C) H&E staining of organoid section at day 2. D-D’) Immunofluorescence analyses detecting early mesodermal markers TBXT and VIM. E) Immunofluorescence analyses detecting early mesodermal markers GATA6 and KDR. F) H&E staining showing hollow cavity-like structures in cardiac organoids at day 8. G-G’) Immunofluorescence analyses detecting mesenchymal cells (VIM + ) in close association with cardiomyocytes (TNNT2 + ). H) H&E staining of organoid sections at day 35 of culture. I) Immunofluorescence analyses showing close interaction of fibroblasts (VIM + ) and cardiomyocytes (TNNT2 + ) at day 35 of culture. J) Cardiac organoids progressively gain in size (D0 = 12.2 μm ± 6.85; D7 = 1231 ± 20.31; D25 = 1613 ± 45.43). K) Beating frequency increases over culture time starting from 25 bpm (± 1.9) at day 7 up to 57 bpm (± 10.5) at day 35. Scale in all pictures: 50 µm

Journal: bioRxiv

Article Title: Tissue resident macrophages innately develop in a human iPSC-derived cardiac organoid model

doi: 10.1101/2025.05.20.654824

Figure Lengend Snippet: A) Schematic representation of the cardiac organoid differentiation protocol. B) Semiquantitative RT-PCR detecting mesodermal ( TBXT, KDR, GATA4 ), cardiac ( NKX2 . 5, TBX5, ISL1, TNNT2, DES, RYR2 ), and endothelial ( PECAM1 ) marker gene expression. C) H&E staining of organoid section at day 2. D-D’) Immunofluorescence analyses detecting early mesodermal markers TBXT and VIM. E) Immunofluorescence analyses detecting early mesodermal markers GATA6 and KDR. F) H&E staining showing hollow cavity-like structures in cardiac organoids at day 8. G-G’) Immunofluorescence analyses detecting mesenchymal cells (VIM + ) in close association with cardiomyocytes (TNNT2 + ). H) H&E staining of organoid sections at day 35 of culture. I) Immunofluorescence analyses showing close interaction of fibroblasts (VIM + ) and cardiomyocytes (TNNT2 + ) at day 35 of culture. J) Cardiac organoids progressively gain in size (D0 = 12.2 μm ± 6.85; D7 = 1231 ± 20.31; D25 = 1613 ± 45.43). K) Beating frequency increases over culture time starting from 25 bpm (± 1.9) at day 7 up to 57 bpm (± 10.5) at day 35. Scale in all pictures: 50 µm

Article Snippet: Primary antibodies against PECAM1 (CD31) (DAKO, M0823), Vimentin (Invitrogen, MA5-6409), ACTN1 (Abcam, Ab68167), KDR (Miltenyi, 130-125-988), TBXT (R&D Systems, AF2085), TNNT2 (Life Technologies, MA512960), CD34 (Life Technologies, MA5-32059), AIF1 (WAKO/Fuji Film, 019-19741) and CD45 (Life Technologies, 14-0451-82) were diluted in NBS blocking solution and incubated overnight at 4 °C.

Techniques: Reverse Transcription Polymerase Chain Reaction, Marker, Gene Expression, Staining, Immunofluorescence

Reagents and resources list for MRPEC isolation.

Journal: Frontiers in Cardiovascular Medicine

Article Title: A refined protocol for the isolation and monoculture of primary mouse renal peritubular endothelial cells

doi: 10.3389/fcvm.2023.1114726

Figure Lengend Snippet: Reagents and resources list for MRPEC isolation.

Article Snippet: CD309 (VEGFR-2) antibody, APC, REAfinity , Recombinant human IgG1; Human anti-Mouse Monoclonal (REA1116) , 1:50 , Miltenyi Biotec , 130-119-434.

Techniques: Isolation, Immunofluorescence, Staining, Flow Cytometry, Recombinant, Concentration Assay, Control, Sterility, Membrane, Cell Culture, Centrifugation, Polymer, Blocking Assay, Purification, Binding Assay, Clinical Proteomics

Immunohistochemical staining for the expression of vascular markers. Positive staining for CD-31 is shown at days (A) 20, (B) 40 and (C) 60; positive staining for Factor-VIII is shown at days (D) 20, (E) 40 and (F) 60; and positive staining of VEGFR2 is shown at days (G) 20, (H) 40 and (I) 60. The black arrows indicate the presence of the vascular markers (yellow). CD-31, cluster of differentiation 31; VEGFR2, vascular endothelial growth factor receptor 2.

Journal: Molecular Medicine Reports

Article Title: Implantation of engineered conduction tissue in the rat heart

doi: 10.3892/mmr.2019.9933

Figure Lengend Snippet: Immunohistochemical staining for the expression of vascular markers. Positive staining for CD-31 is shown at days (A) 20, (B) 40 and (C) 60; positive staining for Factor-VIII is shown at days (D) 20, (E) 40 and (F) 60; and positive staining of VEGFR2 is shown at days (G) 20, (H) 40 and (I) 60. The black arrows indicate the presence of the vascular markers (yellow). CD-31, cluster of differentiation 31; VEGFR2, vascular endothelial growth factor receptor 2.

Article Snippet: Excess solution was discarded and the sections were incubated at 4°C overnight with primary antibodies, including rabbit anti-rat CD-31 (cat. no. BA2966; 1:200), Factor-VIII (cat. no. PB0273; 1:100) and VEGFR2 (cat. no. A00901; 1:500; Wuhan Boster Biological Technology, Ltd., Wuhan, China), followed by treatment with goat anti-rabbit peroxidase-conjugated secondary antibody (cat. no. ab6721; 1:1,000; Abcam) for 1 h at room temperature for visualization with 3-diaminobenzidine tetrahydrochloride.

Techniques: Immunohistochemical staining, Staining, Expressing

CD133/KDR-positive cells were detected in peripheral blood and identified as circulating EPCs by flow cytometry using counting beads tubes. a Gated and counted beads from a fluorescein isothiocyanate (FITC) versus side-scattering corner (SSC) dot plot. Quadrants were set on the basis of isotype-identical controls. b Dual-positive CD133/KDR cells were identified and numerated in the upper right quadrant of the scatter plot from blood of dogs. The representative dot plots are represented. The absolute counts of positive cells per ml blood were calculated using the equation described in “Methods”. c Comparison of circulating EPCs number before and after PAH. d Differentiated EPCs were significantly reduced in PAH but transiently raised at the early stage after DHMC. Data are mean ± SD. *p < 0.05 versus baseline, # p < 0.05 versus 48 h

Journal: The Journal of Physiological Sciences : JPS

Article Title: Senescent endothelial progenitor cells from dogs with pulmonary arterial hypertension: a before–after self-controlled study

doi: 10.1007/s12576-009-0053-7

Figure Lengend Snippet: CD133/KDR-positive cells were detected in peripheral blood and identified as circulating EPCs by flow cytometry using counting beads tubes. a Gated and counted beads from a fluorescein isothiocyanate (FITC) versus side-scattering corner (SSC) dot plot. Quadrants were set on the basis of isotype-identical controls. b Dual-positive CD133/KDR cells were identified and numerated in the upper right quadrant of the scatter plot from blood of dogs. The representative dot plots are represented. The absolute counts of positive cells per ml blood were calculated using the equation described in “Methods”. c Comparison of circulating EPCs number before and after PAH. d Differentiated EPCs were significantly reduced in PAH but transiently raised at the early stage after DHMC. Data are mean ± SD. *p < 0.05 versus baseline, # p < 0.05 versus 48 h

Article Snippet: Briefly, 50 μl of well-mixed anticoagulated whole blood was incubated with PE-labeled mouse anti-dog KDR antibody (Becton Dickinson) and APC-labeled mouse anti-human CD133 antibody (Miltenyi Biotec, Krohne, Germany) in manufacturer-recommended concentrations just above the stainless steel retainer of the tube for 30 min at 4°C.

Techniques: Flow Cytometry, Comparison